In vitro versus in vivo: advanced models to replace animals

In this whitepaper, Sartorius discusses the need to replace animal testing with advanced in vitro human cell models for pharmaceutical, chemical, and cosmetic development as, with only 5-10% of compounds entering clinical trials ultimately gaining approval,  animal studies often fail to translate to humans.

The White Paper details recent regulatory changes in the pre-clinical testing space and showcases advanced in vitro models, such as reconstructed human tissue, which can be used as substitutes for animal model tests for irritation and corrosion in the skin and eye.

Complete the form to download the White Paper

This Application Note is part of the BioTechniques In Focus on NAMs, in association with Sartorius. Check out the animated video, interview and infographic to learn more.

This content was supported by Sartorius.